Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs

Sara A. Tokarz, Jiaqing Pang, Anna Grosz, J. Beth Kempton, Dennis Trune, De Ann M Pillers

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Conclusion: Age-related differences in the expression of inflammatory cytokines in the inner ear may contribute to the development of age-related hearing loss (ARHL). Objectives: ARHL is characterized by tissue remodeling, ischemia, ion homeostasis, and inflammation. Steroid therapy is an otoprotective strategy that likely acts by reducing inflammation. We examined age-related changes in cytokine gene expression in the cochlea of the BALB/cJ mouse model of premature ARHL after systemic or intratympanic steroid delivery. Methods: 'Young' (2.5-3 months) and 'Old' (5-9 months) mice were treated with dexamethasone or fludrocortisone administered either orally or intratympanically. Cytokine gene expression in cochlear RNA was analyzed using prefabricated cDNA arrays. Old groups were compared to Young groups to identify age-related changes. Results: Down-regulation of a cytokine associated with bone remodeling (SPP1) was observed in the untreated Old group. Numerous genes were up-or down-regulated by more than twofold by steroid treatment, including proinflammatory interleukins (IL-16) and anti-inflammatory cytokines.

Original languageEnglish (US)
Pages (from-to)685-691
Number of pages7
JournalActa Oto-Laryngologica
Volume133
Issue number7
DOIs
StatePublished - Jul 2013

Fingerprint

Cochlea
Steroids
Cytokines
Gene Expression
Interleukin-16
Hearing Loss
Pharmaceutical Preparations
Fludrocortisone
Inflammation
Bone Remodeling
Inner Ear
Oligonucleotide Array Sequence Analysis
Dexamethasone
Homeostasis
Anti-Inflammatory Agents
Down-Regulation
Ischemia
RNA
Ions
Genes

Keywords

  • Aging
  • Animal model
  • Glucocorticoid
  • Inflammation
  • Inner ear
  • Mineralocorticoid
  • Sensorineural hearing loss
  • SPP1

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs. / Tokarz, Sara A.; Pang, Jiaqing; Grosz, Anna; Beth Kempton, J.; Trune, Dennis; Pillers, De Ann M.

In: Acta Oto-Laryngologica, Vol. 133, No. 7, 07.2013, p. 685-691.

Research output: Contribution to journalArticle

Tokarz, Sara A. ; Pang, Jiaqing ; Grosz, Anna ; Beth Kempton, J. ; Trune, Dennis ; Pillers, De Ann M. / Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs. In: Acta Oto-Laryngologica. 2013 ; Vol. 133, No. 7. pp. 685-691.
@article{002d4d1d673b477b8bce07b466bc1adc,
title = "Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs",
abstract = "Conclusion: Age-related differences in the expression of inflammatory cytokines in the inner ear may contribute to the development of age-related hearing loss (ARHL). Objectives: ARHL is characterized by tissue remodeling, ischemia, ion homeostasis, and inflammation. Steroid therapy is an otoprotective strategy that likely acts by reducing inflammation. We examined age-related changes in cytokine gene expression in the cochlea of the BALB/cJ mouse model of premature ARHL after systemic or intratympanic steroid delivery. Methods: 'Young' (2.5-3 months) and 'Old' (5-9 months) mice were treated with dexamethasone or fludrocortisone administered either orally or intratympanically. Cytokine gene expression in cochlear RNA was analyzed using prefabricated cDNA arrays. Old groups were compared to Young groups to identify age-related changes. Results: Down-regulation of a cytokine associated with bone remodeling (SPP1) was observed in the untreated Old group. Numerous genes were up-or down-regulated by more than twofold by steroid treatment, including proinflammatory interleukins (IL-16) and anti-inflammatory cytokines.",
keywords = "Aging, Animal model, Glucocorticoid, Inflammation, Inner ear, Mineralocorticoid, Sensorineural hearing loss, SPP1",
author = "Tokarz, {Sara A.} and Jiaqing Pang and Anna Grosz and {Beth Kempton}, J. and Dennis Trune and Pillers, {De Ann M}",
year = "2013",
month = "7",
doi = "10.3109/00016489.2013.771407",
language = "English (US)",
volume = "133",
pages = "685--691",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Age-related cochlear cytokine gene expression in the BALB/cJ mouse with systemic versus intratympanic dosing of steroid drugs

AU - Tokarz, Sara A.

AU - Pang, Jiaqing

AU - Grosz, Anna

AU - Beth Kempton, J.

AU - Trune, Dennis

AU - Pillers, De Ann M

PY - 2013/7

Y1 - 2013/7

N2 - Conclusion: Age-related differences in the expression of inflammatory cytokines in the inner ear may contribute to the development of age-related hearing loss (ARHL). Objectives: ARHL is characterized by tissue remodeling, ischemia, ion homeostasis, and inflammation. Steroid therapy is an otoprotective strategy that likely acts by reducing inflammation. We examined age-related changes in cytokine gene expression in the cochlea of the BALB/cJ mouse model of premature ARHL after systemic or intratympanic steroid delivery. Methods: 'Young' (2.5-3 months) and 'Old' (5-9 months) mice were treated with dexamethasone or fludrocortisone administered either orally or intratympanically. Cytokine gene expression in cochlear RNA was analyzed using prefabricated cDNA arrays. Old groups were compared to Young groups to identify age-related changes. Results: Down-regulation of a cytokine associated with bone remodeling (SPP1) was observed in the untreated Old group. Numerous genes were up-or down-regulated by more than twofold by steroid treatment, including proinflammatory interleukins (IL-16) and anti-inflammatory cytokines.

AB - Conclusion: Age-related differences in the expression of inflammatory cytokines in the inner ear may contribute to the development of age-related hearing loss (ARHL). Objectives: ARHL is characterized by tissue remodeling, ischemia, ion homeostasis, and inflammation. Steroid therapy is an otoprotective strategy that likely acts by reducing inflammation. We examined age-related changes in cytokine gene expression in the cochlea of the BALB/cJ mouse model of premature ARHL after systemic or intratympanic steroid delivery. Methods: 'Young' (2.5-3 months) and 'Old' (5-9 months) mice were treated with dexamethasone or fludrocortisone administered either orally or intratympanically. Cytokine gene expression in cochlear RNA was analyzed using prefabricated cDNA arrays. Old groups were compared to Young groups to identify age-related changes. Results: Down-regulation of a cytokine associated with bone remodeling (SPP1) was observed in the untreated Old group. Numerous genes were up-or down-regulated by more than twofold by steroid treatment, including proinflammatory interleukins (IL-16) and anti-inflammatory cytokines.

KW - Aging

KW - Animal model

KW - Glucocorticoid

KW - Inflammation

KW - Inner ear

KW - Mineralocorticoid

KW - Sensorineural hearing loss

KW - SPP1

UR - http://www.scopus.com/inward/record.url?scp=84879069754&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879069754&partnerID=8YFLogxK

U2 - 10.3109/00016489.2013.771407

DO - 10.3109/00016489.2013.771407

M3 - Article

C2 - 23768053

AN - SCOPUS:84879069754

VL - 133

SP - 685

EP - 691

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 7

ER -